Skip to content
StockMarketAgent
Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

BVL/GILD stock hub

BVL/GILD has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

BVL/GILDis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
561.4B
Lima Stock Exchange
Market data

Price

Recent price action with selectable time range.

BVL/GILDBVL/GILD
—
Loading chart…
In the news

Latest news · BVL/GILD

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/E17.5
P25 n/aP50 n/aP75 n/a
ROE43.4
P25 n/aP50 n/aP75 n/a
ROIC27.7
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All BVL/GILD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
209
Groups with data
11
Currency
USD
Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
United States
Country code
PE
Employees
17,000
Employees Change
-600%
Employees Change Percent
-3.41
Enterprise value
$600.3B
Exchange
Lima Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Biological Products, Except Diagnostic Substances
Last refreshed
2026-05-10
Market cap
$561.4B
Price
$132
Price currency
USD
Rev Per Employee
6,106,200.14x
Sic
2836
Symbol
bvl/GILD
Website
https://www.gilead.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
5.73%
EV Earnings
18.66x
EV/EBIT
14.55x
EV/EBITDA
11.7x
EV/FCF
16.81x
EV/Sales
5.86x
FCF yield
6.36%
P/B ratio
6.86x
P/E ratio
17.45x
P/S ratio
5.41x
PE Ratio10 Y
73.41x
PE Ratio3 Y
123.96x
PE Ratio5 Y
81.56x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
40.3%
EBITDA Margin
49.56%
FCF margin
34.4%
Gross margin
79.37%
Gross Profit
$82.4B
Gross Profit Growth
4.91%
Gross Profit Growth Q
7.57%
Gross Profit Growth3 Y
3.3%
Gross Profit Growth5 Y
1.9%
Net Income
$32.2B
Net Income Growth
54.5%
Net Income Growth Q
53.69%
Net Income Growth3 Y
18.18%
Net Income Growth5 Y
98.24%
Pretax Margin
36.07%
Profit Margin
30.99%
Profit Per Employee
$1.9M
ROA
13.29
Roa5y
10.85
ROCE
25.61
ROE
43.36
Roe5y
24.33
ROIC
27.7
Roic5y
21.93

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

20
MetricValue
Cagr1y
22.7%
Cagr3y
22.51%
Cagr5y
20.01%
EPS Growth
55.43
EPS Growth Q
54.81
EPS Growth3 Y
18.49
EPS Growth5 Y
98.31
FCF Growth
3.92%
FCF Growth Q
46.82%
FCF Growth3 Y
6.85%
FCF Growth5 Y
3.3%
OCF Growth
4.25%
OCF Growth Q
44.79%
OCF Growth10 Y
-5.37%
OCF Growth3 Y
6.38%
OCF Growth5 Y
2.95%
Revenue Growth
3.48x
Revenue Growth Q
4.4x
Revenue Growth3 Y
3.21x
Revenue Growth5 Y
3.07x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
$0.53
Assets
$196.5B
Cash
$34.3B
Current Assets
$64.2B
Current Liabilities
$32.7B
Debt
$77.4B
Debt EBITDA
$1.49
Debt Equity
$0.95
Debt FCF
$2.17
Equity
$81.8B
Interest Coverage
11.94
Liabilities
$114.7B
Long Term Assets
$132.2B
Long Term Liabilities
$82B
Net Cash
$-39.7B
Net Cash By Market Cap
$-7.07
Net Debt EBITDA
$0.77
Net Debt Equity
$0.49
Net Debt FCF
$1.11
Tangible Book Value
$-4.1B
Tangible Book Value Per Share
$-3.32

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.97
Inventory Turnover
3.34
Net Working Capital
$2.3B
Quick ratio
1.54
Working Capital
$32B
Working Capital Turnover
$15.13

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
0.34%
Payout Ratio
43.76%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

34
MetricValue
1Y total return
22.68%
200-day SMA
115.3
3Y total return
83.89%
50-day SMA
124.9
50-day SMA vs 200-day SMA
50over200
5Y total return
148.89%
All Time High
131.5
All Time High Change
0%
All Time High Date
2026-04-30
All Time Low
60.08
All Time Low Change
118.87%
All Time Low Date
2022-02-28
ATR
0.77
Ch YTD
19.27
High
131.5
High52
131.5
High52 Date
2026-04-30
High52ch
0%
Low
131.5
Low52
110.3
Low52 Date
2026-01-20
Low52ch
19.27%
Ma50ch
5.27%
Price vs 200-day SMA
14.01%
RSI
78.7
RSI Monthly
89.58
RSI Weekly
99.61
Sharpe ratio
1.23x
Sortino ratio
10.52
Total Return
0.34%
Tr YTD
20.07
Tr1m
5.62%
Tr1w
5.62%
Tr3m
6.32%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
$41.8B
Operating Income Growth
9.44
Operating Income Growth Q
6.55
Operating Income Growth3 Y
5.45
Operating Income Growth5 Y
0.53
Operating margin
40.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
1,239,252,307%
Net Borrowing
-9,620,534,000
Shares Insiders
0.1%
Shares Institutions
89.54%
Shares Qo Q
0.08%
Shares Yo Y
-0.34%
Short Ratio
3.53

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

58
MetricValue
Adjusted FCF
$32.6B
Average Volume
7.3x
Bv Per Share
66.09
CAPEX
$-2B
Ch1m
5.62
Ch1w
5.62
Ch1y
19.27
Ch3m
5.62
Ch3y
66.04
Ch5y
106.4
Ch6m
19.27
Change
1.65%
Change From Open
0
Close
129.4
Days Gap
1.65
Depreciation Amortization
9,486,149,750
Dollar Volume
5,786
Earnings Date
2026-05-07
EBIT
$41.8B
EBITDA
$51.4B
EPS
$25.67
F Score
8
FCF
$35.7B
FCF EV Yield
5.95x
Financing CF
-29,875,122,200
Fiscal Year End
December
Founded
1,987
Goodwill
28,647,965,500
Graham Number
56.99494
Graham Upside
-56.66
Income Tax
$5.3B
Investing CF
-9,104,267,200
Is Primary Listing
0
Last Earnings Date
2026-05-07
Last Report Date
2026-03-31
Lynch Fair Value
$188
Lynch Upside
43.26
Ma150
117
Ma150ch
12.35%
Ma20
125.6
Ma20ch
4.74%
Net CF
-1,036,797,300
Next Earnings Date
2026-08-06
Open
131.5
P FCF Ratio
15.72
P OCF Ratio
14.88
Ppne
19,427,138,500
Price Date
2026-04-30
Price EBITDA
$10.91
Relative Volume
6.03x
Revenue
103,805,402,400x
SBC By Revenue
3.04x
Share Based Comp
3,152,282,700
Tax By Revenue
5.08x
Tax Rate
14.09%
Tr6m
20.93%
Volume
44
Z Score
4.51
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does BVL/GILD pay a dividend?

Capital-return profile for this ticker.

Performance

BVL/GILD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+22.7%
S&P 500 1Y: n/a
3Y total return
+83.9%
S&P 500 3Y: n/a
5Y total return
+148.9%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns BVL/GILD?

Insider, institutional, and short-interest positioning.

Institutional ownership
+89.5%
Share of float held by funds and institutions
Insider ownership
+0.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
3.5 days to cover
Y/Y dilution
-0.3%
Negative means the company is buying back shares.
Technical

BVL/GILD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
78.7
Above 70: short-term overbought
Price vs 200-day MA
+14.0%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
1.23
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About BVL/GILD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvl/GILD stock rating?

bvl/GILD is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvl/GILD analysis?

The full report lives at /stocks/bvl/GILD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvl/GILD?

The latest report frames bvl/GILD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvl/GILD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.